A look behind the scenes into the planning of the AACR Annual Meeting, including the scientific program, conference logistics,...
Several clinical trials are underway in which PARP inhibitors are being tested in breast cancers, mostly triple-negative breast cancers,...
Paul Northcott, PhD, inaugural recipient of the AACR NextGen Grant for Transformative Cancer Research, has dedicated his research career...
Beginning this Friday, Philadelphia will host the 2017 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. The conference,...
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a revolutionary new type of immunotherapy...
Despite advances in treatment, nearly 1,800 children and adolescents in the U.S. die annually from cancer. In an article...
For the second consecutive year, the American Association for Cancer Research (AACR) has been designated the beneficiary of Party...
Cancer cells ingest copious amounts of the simple sugar glucose. This addiction may hold the key to how cancer...
In recent years, the U.S. Food and Drug Administration has approved immune checkpoint inhibitors, a class of immunotherapy, to...
Mubarak Labaran Liman has overcome the death of his father and a scarcity of resources to develop a thriving...
Scientific advancements are made through scientific research. From understanding the basic biology behind a disease to testing how well...